Pathogenesis of Autoimmune Disease Flashcards

(31 cards)

1
Q

Give examples of autoimmune musculoskeletal disorders

A

Rheumatoid arthritis
Ankylosing spondylitis
Systemic Lupus Erythematosus (SLE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are HLA molecules

A

Human leukocyte antigens
The first regions of the MHC to be sequenced
genes within the MHC class I and class II regions encode cell surface proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which MHC gene is associated with Rheumatoid arthritis

A

HLA-DR-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which MHC gene is associated with systemic lupus erythematosus

A

HLA-DR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which MHC gene is associated with Ankylosing spondylitis

A

HLA-B27

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe MHC class I (expression, antigen, recognition and response)

A

Found in all nucleated cells
Endogenous antigen
CD8 +ve T cells
Cell killing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe MHC class II (expression, antigen, recognition and response)

A

Found in antigen presenting cells
Exogenous antigens
CD4 +ve T cells
Antibody response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give examples of APCs

A

Dendritic Cells
B cells
Macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give examples of endogenous and exogenous antigens

A

Endogenous - viral peptide, tumour antigen, self-peptides

Exogenous - Bacterial peptides, self peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the key auto-antibodies in rheumatoid arthritis

A

Rheumatoid factor

Anti-cyclic citrullinated peptide antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the key auto-antibodies in systemic lupus erythematosus

A
Antinuclear antibodies (ANA)
Anti-double stranded DNA antibodies (anti-dsDNA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the disease activity in systemic lupus erythematosus

A

Low complement levels

High serum levels of anti-ds-DNA antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the pathogenesis of systemic lupus erythematosus

A
  1. Apoptosis leads to translocation of nuclear antigens to membrane surface
  2. Impaired clearance of apoptotic cells results in enhanced presentation of nuclear antigens to immune cells
  3. B cell autoimmunity
  4. Tissue damage by antibody effector mechanisms e.g. complement activation and Fc receptor engagement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What cytokines are release by T cells and what are their effects

A

γ-IFN - Activated macrophages
IL-2 - Activates T and B cells
IL-6 - Activates B cells, acute phase response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What cytokines are release by macrophages and what are their effects

A

IL-1 - Activates T cells, fever, pro-inflammatory

TNF-alpha - similar to IL-1, more destructive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What cytokines do Th1 cells release and what are they involved in

A

IL-2 and γ-IFN

Response is important in CD8 +ve cytotoxicity and macrophage stimulation

17
Q

What cytokines do Th2 cells release and what are they involved in

A

IL-4 (IgE responses)
IL-5 (eosinophils)
IL-6 (B cells to plasma cells)
IL-10 (inhibit macrophage response)

18
Q

What cytokines do Th17 cells release and what are they involved in

A

develop in response to IL-23 Secrete IL-17, a potent cytokine which triggers IL-6, IL-8, TNFα, matrix metalloproteinases and RANKL in target cells
Important in mucosal immunity but also in disease including arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis

19
Q

What is RANKL and what is it produced by

A

RANKL (receptor activator of nuclear factor kappa-B ligand)

Produced by T cells and synovial fibroblasts in rheumatoid arthritis

20
Q

What is the action of RANKL

A

Stimulates osteoclast formation

21
Q

What is RANKL unregulated by

A

Interleukin-1, TNF-alpha

Interleukin-17 – potent action on osteoclastogenesis via RANKL-RANK pathway

PTH-related peptide

22
Q

Give an example of a drug used that targets RANKL

A

Denosumab – monoclonal antibody against RANKL

indicated for treatment of osteoporosis, bone metastases, multiple myeloma and Giant cell tumours

23
Q

Give examples of therapies use for SLE therapy

A

Rituximab - chimeric anti-CD20 used to deplete B cells

Belimumab - monoclonal antibody against B cell survival factor BLYS

24
Q

What are prostaglandins

A

lipid mediators of inflammation that act on platelets, endothelium, uterine tissue and mast cells

25
How are prostaglandins synthesised
Phospholipase A2 generates arachidonic acid from diacylglycerol in cell membranes. Arachidonic acid enters two pathways: cyclooxygenase (prostaglandins) or lipooxygenase (leukotrienes)
26
What are the actions of prostaglandins
Prostaglandins mediate vasodilatation (PGI2), inhibit platelet aggregation (PGI2), bronchodilatation (e.g. PGE2 acting via receptor called EP2, PGI2), uterine contraction (PGF2alpha)
27
What is ankylosing spondylitis and describe the immunology
``` Chronic spinal inflammation that can result in spinal fusion and deformity Site of inflammation is the enthesis No autoantibodies (‘seronegative’) ```
28
Which musculoskeletal diseases are not associated with any auto-antibodies
Osteoarthritis Reactive arthritis Gout Ankylosing spondylitis
29
Describe the use of antinuclear antibodies (ANA) in SLE
Seen in all SLE cases | Not specific for SLE
30
Describe the use of anti-double stranded DNA antibodies
Specific for SLE | Serum level of antibody correlates with disease activity
31
Give examples of treatments that target B cells in SLE
rituximab - chimeric anti-CD20 antibody used to deplete B cells belimumab - monoclonal antibody against a B cell survival factor call BLYS